Vyzkoušejte nový nástroj s podporou AI
Summon Research Assistant
BETA
Abstract 11598: In Silico Identification of Immunogenic Cardiac Troponin I Epitopes and Validation in Patients Treated With Immune Checkpoint Inhibitors
Xu, Shirley, Pechenik, Peninah, Kattel, Sharma, Sonkawade, Swati D, Nepali, Sarmila, Ito, Fumito, Sharma, Umesh C, Pokharel, Saraswati
Published in Circulation (New York, N.Y.) (08.11.2022)
Published in Circulation (New York, N.Y.) (08.11.2022)
Get full text
Journal Article
Addition of immune checkpoint inhibitors to chemotherapy versus chemotherapy alone in patients with triple‐negative breast cancer: A systematic review and meta‐analysis
Gao, Xin, Zhu, Ying, Wang, Peipei, Yu, Lulin, Ruan, Shanming, Shen, Minhe, Zhang, Kai
Published in Cancer medicine (Malden, MA) (01.12.2023)
Published in Cancer medicine (Malden, MA) (01.12.2023)
Get full text
Journal Article
Low lymphocyte counts and association with clinical outcomes in hospitalized patients with cancer receiving immune checkpoint inhibitor therapy
Young, Richard, Panchal, Hemali, Ma, Weijie, Chen, Shuai, Steele, Aaron Paul, Iannucci, Andrea A., Li, Tianhong
Published in Journal of clinical oncology (01.06.2022)
Published in Journal of clinical oncology (01.06.2022)
Get full text
Journal Article
Repeated SARS-CoV-2 vaccination in cancer patients treated with immune checkpoint inhibitors: induction of high-avidity anti-RBD neutralizing antibodies
Caruso, Teresita, Salani, Francesca, Catanese, Silvia, Pratesi, Federico, Mercinelli, Chiara, Motta, Giuseppe, Genovesi, Virginia, Bonato, Adele, Sara, Galimberti, Masi, Gianluca, Migliorini, Paola
Published in International journal of clinical oncology (01.03.2023)
Published in International journal of clinical oncology (01.03.2023)
Get full text
Journal Article
Predictive biomarkers of response to immune checkpoint inhibitors
María Sacramento Díaz-Carrasco, Eva González-Haba, Juana Inés García-Soler, Alberto Espuny-Miró
Published in Farmacia hospitalaria (01.07.2020)
Published in Farmacia hospitalaria (01.07.2020)
Get full text
Journal Article
358 Trial in progress: A pilot study of combined immune checkpoint inhibition in combination with ablative therapies in subjects with hepatocellular carcinoma (HCC)
Carroll, Hailey, Aleem, Umair, Varghese, Pooja, Galligan, Marie, Bourke, Michèle, Hoey, Katherine, Ryan, Ronan, Doran, Peter, Stewart, Stephen, O’Farrelly, Cliona, Greten, Tim, Houlihan, Diarmaid, McDermott, Raymond, Duffy, Austin
Published in Journal for immunotherapy of cancer (01.11.2020)
Published in Journal for immunotherapy of cancer (01.11.2020)
Get full text
Journal Article
Immune checkpoint inhibitor-induced endocrinopathies: a possible indicator of improved survival
Ornelas, Mariana, Borges-Canha, Marta, Gouveia, Pedro, Ferreira, Margarida, Resende, Eduarda, Sá, Maritza, Abreu, Silvestre
Published in Archives of Endocrinology and Metabolism (19.06.2023)
Published in Archives of Endocrinology and Metabolism (19.06.2023)
Get full text
Journal Article
REFINE (REduced Frequency ImmuNE checkpoint inhibition in cancers): A multi-arm phase II basket trial testing reduced intensity immunotherapy across different cancers
Merrick, Sophie, Nankivell, Matthew, Quartagno, Matteo, Clarke, Caroline S., Joharatnam-Hogan, Nalinie, Waddell, Tom, O'Carrigan, Brent, Seckl, Michael, Ghorani, Ehsan, Banks, Emma, Edmonds, Kim, Bray, George, Woodward, Rose, Bennett, Rachel, Badrock, Jonathan, Hudson, Will, Langley, Ruth E., Vasudev, Naveen, Pickering, Lisa, Gilbert, Duncan C.
Published in Contemporary clinical trials (01.01.2023)
Published in Contemporary clinical trials (01.01.2023)
Get full text
Journal Article
Investigation of the status of immune checkpoint molecules (PD-L1 and PD-1) in meningiomas by immunohistochemistry
SAYGIN, İSMAİL, ÇAKIR, EMEL, KAZAZ, SEHER NAZLI, GÜVERCİN, ALİ RIZA, EYÜPOĞLU, İLKER, USTAOĞLU, MÜŞERREF MÜGE
Published in Turkish journal of medical sciences (01.01.2024)
Published in Turkish journal of medical sciences (01.01.2024)
Get full text
Journal Article
Adverse events (AEs) of immune checkpoint therapy (ICT) combined with vascular endothelial growth factor inhibitors (VEGFi) vs. ICT alone: A pooled meta-analysis of 1735 patients
Ng, Wern Lynn, Geng, Yimin, Benkhadra, Raed, Msaouel, Pavlos, Alhalabi, Omar
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Meta-analysis of efficacy outcome measures across immune checkpoint inhibitors (ICIs) and targeted therapies (TTs) in melanoma to guide future clinical trial design
Ahadieh, Sima, Di Pietro, Alessandra, Sturtz, Keren, Williams, Jason H., Fetterly, Gerald
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
AI-based radiomic biomarkers to predict PD-(L)1 immune checkpoint inhibitor response within PD-L1 high/low/negative expression categories in stage IV NSCLC
Jordan, Petr, Sako, Chiharu, Beasley, Ryan, Owen, Dwight Hall, Patel, Arpan, Curti, Brendan D., Weerasinghe, Roshanthi K., Lee, Soohee, Amini, Arya, Liu, An, Page, Ray D., Swalduz, Aurélie, Beregi, Jean-Paul, Sanchez, Stéphane, Gevaert, Olivier, Parikh, Ravi Bharat, Aerts, Hugo
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Immune checkpoint inhibitors, endocrine adverse events, and outcomes of melanoma
Karhapää, Hanna, Mäkelä, Siru, Laurén, Hanna, Jaakkola, Marjut, Schalin-Jäntti, Camilla, Hernberg, Micaela
Published in Endocrine Connections (01.02.2022)
Published in Endocrine Connections (01.02.2022)
Get full text
Journal Article
Comparison of efficacy and safety between neoadjuvant chemotherapy and neoadjuvant immune checkpoint inhibitors combined with chemotherapy for locally advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis
Xu, Jinxin, Cai, Yingjie, Hong, Zhinuan, Duan, Hongbing, Ke, Sunkui
Published in International journal of surgery (London, England) (01.01.2024)
Published in International journal of surgery (London, England) (01.01.2024)
Get full text
Journal Article
Bayesian Networks to Support Decision-Making for Immune-Checkpoint Blockade in Recurrent/Metastatic (R/M) Head and Neck Squamous Cell Carcinoma (HNSCC)
Huehn, Marius, Gaebel, Jan, Oeser, Alexander, Dietz, Andreas, Neumuth, Thomas, Wichmann, Gunnar, Stoehr, Matthaeus
Published in Cancers (23.11.2021)
Published in Cancers (23.11.2021)
Get full text
Journal Article
An Open‐Label Phase II Trial of Pembrolizumab, an Immune Checkpoint Inhibitor Alone or in Combination With Oral Azacitidine as Second‐Line Therapy for Advanced Head and Neck Squamous Cell Cancers
Ramani, Vinod K., Gayen, Srimonta, Naik, Radheshyam
Published in Health science reports (01.01.2025)
Published in Health science reports (01.01.2025)
Get full text
Journal Article
Durable complete response for oligometastatic renal cell carcinoma with immune checkpoint inhibition and cytoreductive nephrectomy in a Jehovah’s witness: A case report
Zhuang, Tony Zibo, Harik, Lara, Force, Seth, Hadadi, Agreen, Bilen, Mehmet Asim, Brown, Jacqueline T., Carthon, Bradley C., Goldman, Jamie, Kucuk, Omer, Master, Viraj A., Nazha, Bassel
Published in Frontiers in oncology (02.12.2022)
Published in Frontiers in oncology (02.12.2022)
Get full text
Journal Article
Pseudo-Progression and the Neutrophil-to-Lymphocyte Ratio in Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors: A Case–Control Study
Kiriu, Tatsunori, Yamamoto, Masatsugu, Nagano, Tatsuya, Hazama, Daisuke, Sekiya, Reina, Katsurada, Masahiro, Katsurada, Naoko, Tachihara, Motoko, Kobayashi, Kazuyuki, Nishimura, Yoshihiro
Published in OncoTargets and therapy (01.12.2019)
Published in OncoTargets and therapy (01.12.2019)
Get full text
Journal Article